These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 1241686)
1. Cell-mediated immunologic status of healthy members of families with a history of leprosy. Price MA; Anders EM; Anders RF; Russel DA; Dennis ES Int J Lepr Other Mycobact Dis; 1975; 43(4):307-13. PubMed ID: 1241686 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test. Job CK; Chacko CJ; Taylor PM; Daniel M; Jesudian G Int J Lepr Other Mycobact Dis; 1976; 44(1-2):256-66. PubMed ID: 776862 [TBL] [Abstract][Full Text] [Related]
3. A study of cellular immunity in clinically healthy children of parents with leprosy in northern Thailand. Nelson KE; Speck SM; Suprasert S; Smith T Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):147-53. PubMed ID: 6539306 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiological immunological studies on leprosy in Okinawa. 6. Lepromin, lymphocyte transformation, FLA-ABS and leproagglutination tests in the in-and out-patients with leprosy and the relationships among these tests and personal or family history or clinical findings of the patients]. Minagawa F; Yoshino Y; Abe M; Saito N; Ohsawa Y; Ozawa T; Saikawa K Nihon Rai Gakkai Zasshi; 1989; 58(2):92-111. PubMed ID: 2697714 [TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125 [TBL] [Abstract][Full Text] [Related]
6. A study of the immunological effects of cimetidine in patients with lepromatous leprosy. Brown AE; Nelson KE; Makonkawkeyoon S; Vithayasai V; Scollard DM; Bullock WE Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):559-64. PubMed ID: 3910745 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of cell mediated immunity in healthy contacts of leprosy. Kurhade AM; Akulwar SL; Pathak AA; Thakar YS; Dhanvijay AG Indian J Pathol Microbiol; 1996 Jul; 39(3):197-201. PubMed ID: 8972148 [TBL] [Abstract][Full Text] [Related]
8. Immunoepidemiological studies on subclinical infection among leprosy household contacts in Thailand. Sampatavanich S; Sampoonachot P; Kongsuebchart K; Ramasoota T; Pinrat U; Mongkolwongroi P; Ozawa T; Sasaki N; Abe M Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):752-65. PubMed ID: 2681458 [TBL] [Abstract][Full Text] [Related]
9. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients. Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525 [TBL] [Abstract][Full Text] [Related]
10. Prospective immunological follow-up in household contacts of Mexican leprosy patients. Amezcua ME; Escobar-Gutiérrez A; Barba-Rubio J; Cázares JV; Mayén E; Chávez-Núñez M; Peña RC; Rodríguez R; Pastén S Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115 [TBL] [Abstract][Full Text] [Related]
11. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy. Singh PK; Ratna ; Jain PK; Mital VP Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495 [TBL] [Abstract][Full Text] [Related]
12. HLA-linked control of predisposition to lepromatous leprosy. Xu KY; de Vries RR; Fei HM; van Leeuwen A; Chen RB; Ye GY Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):56-63. PubMed ID: 3858394 [TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy. Anders EM; McAdam KP; Anders RF Clin Exp Immunol; 1977 Jan; 27(1):111-7. PubMed ID: 849644 [TBL] [Abstract][Full Text] [Related]
14. The Kveim test in leprosy. Krishnamurthy S; Verghese R; Job CK Int J Lepr Other Mycobact Dis; 1975; 43(4):333-8. PubMed ID: 1241690 [TBL] [Abstract][Full Text] [Related]
15. DNCB contact sensitization in leprosy: its comparison with other CMI tests. Jayasingh K; Bhatia VN Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491 [TBL] [Abstract][Full Text] [Related]
16. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ; Closs O; Belehu A Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003 [TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical, histological and immunological features across the leprosy spectrum. Narayan NP; Ramu G; Desikan KV; Vallishayee RS Indian J Lepr; 2001; 73(4):329-42. PubMed ID: 11898465 [TBL] [Abstract][Full Text] [Related]
18. [Cellular immunity in leprosy patients]. de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656 [TBL] [Abstract][Full Text] [Related]
19. Histology of the Mitsuda reaction of healthy adults with no known contacts with leprosy patients. Petri V; Mendes EV; Beiguelman B Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):540-5. PubMed ID: 4086917 [TBL] [Abstract][Full Text] [Related]
20. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy. Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]